U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07184970) titled 'PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound' on Sept. 15.
Brief Summary: The purpose of this study is to compare the sensitivity of PSMA PET/MRI and standard MRI in detecting focal therapy failure in the prostate one year after High-Intensity Focused Ultrasound (HIFU) treatment. Specifically, the study aims to evaluate whether PSMA PET/MRI offers a higher sensitivity than MRI alone for identifying recurrence or failure in patients undergoing focal therapy.
Study Start Date: Oct. 01
Study Type: OBSERVATIONAL
Condition:
Prostate Cancer
Recruitment Status: NOT_...